Melanoma News and Research

Latest Melanoma News and Research

New tool predicts melanoma risk

Queensland researchers have come up with a “highly accurate” melanoma detection online tool that can help diagnose the condition within 90 seconds. The test can predict if a person would get the infection within the next three and a half years.

12 Mar 2018

Preventing metabolic exhaustion in immune cells could enhance effects of immunotherapy

If you're an immune cell gearing up to fight cancer, you'd better eat your breakfast. The tumor microenvironment is a harsh place, and tumor cells are ready to wear you out.

6 Mar 2018

Researchers report potential new role for skin bacteria in protecting against cancer

Science continues to peel away layers of the skin microbiome to reveal its protective properties. In a study published in Science Advances on February 28, University of California San Diego School of Medicine researchers report a potential new role for some bacteria on the skin: protecting against cancer.

1 Mar 2018

Never too late to operate? Surgery near end of life is common, costly

At 87, Maxine Stanich cared more about improving the quality of her life than prolonging it. She suffered from a long list of health problems, including heart failure and chronic lung disease that could leave her gasping for breath.

28 Feb 2018

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.

26 Feb 2018

Adding hope to health messages may help promote preventative actions, researchers say

While fear about health concerns may grip people, adding a little hope to a message might make people more willing to take preventative actions, according to researchers.

23 Feb 2018

Zika virus could be alternative for treatment of aggressive brain cancer

Zika virus, feared for causing microcephaly in babies whose mothers were infected during pregnancy by attacking the cells that will give rise to the fetus's cerebral cortex, could be an alternative for treatment of glioblastoma, the most common and aggressive kind of malignant brain tumor in adults.

21 Feb 2018

Key protein involved in epigenetic regulation of gene expression guides skin cell renewal

Approximately once a month, our skin completely renews itself. If this highly coordinated process goes awry, it can lead to a variety of skin diseases, ranging from skin cancer to psoriasis.

19 Feb 2018

Research finds rising trend in incidence of merkel cell carcinoma

Merkel cell carcinoma is a rare type of skin cancer, affecting only a few thousand people each year, compared to tens of thousands with melanoma. But while it may not be as common as other skin cancers, MCC is highly aggressive and often deadly - and it's also becoming more common, according to new research published in the Journal of the American Academy of Dermatology and presented at the American Academy of Dermatology 2018 Annual Meeting in San Diego.

19 Feb 2018

Study reveals parents' views toward children’s tanning bed use

While everyone who climbs into an indoor tanning bed faces an increased risk of skin cancer, this risk is especially pronounced for young people: Using indoor tanning beds before age 35 can increase one's risk of melanoma, the deadliest form of skin cancer, by 59 percent, and this risk increases with each use.

18 Feb 2018

New guidelines offer recommendations for assessment, management of immunotherapy side effects

Immunotherapy with immune checkpoint inhibitors is the first of a new generation of immunotherapy treatments, revolutionizing treatment for many different types of cancer. By unleashing the body's immune system to attack cancer, these treatments can send even the most hard-to-treat cancers into lasting remission.

15 Feb 2018

Study reports longer survival for obese men with metastatic melanoma

Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index, investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts.

13 Feb 2018

Scientists program nanorobots to shrink tumors

In a major advancement in nanomedicine, Arizona State University scientists, in collaboration with researchers from the National Center for Nanoscience and Technology, of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply.

12 Feb 2018

Scientists develop ultrasound-propelled nanomotors for active delivery of Cas9-sgRNA complex

In cancer research, the “Cas-9–sgRNA” complex is an effective genomic editing tool, but its delivery across the cell membrane to the target (tumor) genome has not yet been satisfactorily solved. American and Danish scientists have now developed an active nanomotor for the efficient transport, delivery, and release of this gene scissoring system.

9 Feb 2018

New tool to monitor patterns and trends of cancer burden across Europe

On the occasion of the World Cancer Day, the European Commission's Joint Research Centre launched the European Cancer Information System (ECIS), which makes it possible to explore geographical patterns and temporal trends of cancer incidence, mortality, and survival from data submitted by some 150 European population-based cancer registries.

6 Feb 2018

Researchers use innovative method to screen kinases for cancer drug's effectiveness

In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.

5 Feb 2018

Study lays groundwork for using PD-1 inhibitors against aggressive form of pediatric brain cancer

One type of immunotherapy removes a genetic blindfold that cancer uses to hide from the immune system. These "PD-1 inhibitors", including drugs like pembrolizumab, nivolumab and atezolizumab, have proven useful and have even in some cases revolutionized the treatment of common adult cancers ranging from melanoma, to lung cancer, to kidney cancer and more.

30 Jan 2018

Melanoma News and Research

Latest Melanoma News and Research

New tool predicts melanoma risk

Preventing metabolic exhaustion in immune cells could enhance effects of immunotherapy

Researchers report potential new role for skin bacteria in protecting against cancer

Never too late to operate? Surgery near end of life is common, costly

Repurposing leukemia drugs may be effective approach for treating metastatic melanoma patients

Adding hope to health messages may help promote preventative actions, researchers say

Zika virus could be alternative for treatment of aggressive brain cancer

Key protein involved in epigenetic regulation of gene expression guides skin cell renewal

Research finds rising trend in incidence of merkel cell carcinoma

Study reveals parents' views toward children’s tanning bed use

New guidelines offer recommendations for assessment, management of immunotherapy side effects

Study reports longer survival for obese men with metastatic melanoma

Scientists program nanorobots to shrink tumors

Scientists develop ultrasound-propelled nanomotors for active delivery of Cas9-sgRNA complex

New tool to monitor patterns and trends of cancer burden across Europe

Researchers use innovative method to screen kinases for cancer drug's effectiveness

Study lays groundwork for using PD-1 inhibitors against aggressive form of pediatric brain cancer

Scientists aim to decipher language of DNA

Researchers discover potential target genes to halt thyroid cancer progression

Researchers develop new mathematical tool to solve genetics challenge

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Melanoma News and Research

Latest Melanoma News and Research

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in